EP1649031A1 - Process for the preparation of l-threonine - Google Patents
Process for the preparation of l-threonineInfo
- Publication number
- EP1649031A1 EP1649031A1 EP04763520A EP04763520A EP1649031A1 EP 1649031 A1 EP1649031 A1 EP 1649031A1 EP 04763520 A EP04763520 A EP 04763520A EP 04763520 A EP04763520 A EP 04763520A EP 1649031 A1 EP1649031 A1 EP 1649031A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- process according
- threonine
- removal
- source
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 title claims abstract description 102
- 238000000034 method Methods 0.000 title claims abstract description 79
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000004473 Threonine Substances 0.000 claims abstract description 64
- 229960002898 threonine Drugs 0.000 claims abstract description 64
- 241000894006 Bacteria Species 0.000 claims abstract description 16
- 241000588921 Enterobacteriaceae Species 0.000 claims abstract description 11
- 235000015097 nutrients Nutrition 0.000 claims description 56
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 32
- 239000002028 Biomass Substances 0.000 claims description 31
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 29
- 229910052799 carbon Inorganic materials 0.000 claims description 29
- 238000012258 culturing Methods 0.000 claims description 27
- 239000000047 product Substances 0.000 claims description 26
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 20
- 238000010923 batch production Methods 0.000 claims description 19
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 11
- 229910052698 phosphorus Inorganic materials 0.000 claims description 11
- 239000011574 phosphorus Substances 0.000 claims description 11
- -1 alkaline earth metal salts Chemical class 0.000 claims description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 9
- 229930006000 Sucrose Natural products 0.000 claims description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 229960004793 sucrose Drugs 0.000 claims description 9
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 8
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 8
- 241000588724 Escherichia coli Species 0.000 claims description 8
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 7
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 7
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 7
- 239000001301 oxygen Substances 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 101150076849 rpoS gene Proteins 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 4
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 claims description 4
- 108700028369 Alleles Proteins 0.000 claims description 4
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims description 4
- 239000004254 Ammonium phosphate Substances 0.000 claims description 4
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 claims description 4
- 229930091371 Fructose Natural products 0.000 claims description 4
- 239000005715 Fructose Substances 0.000 claims description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 4
- 235000021536 Sugar beet Nutrition 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- 229910021529 ammonia Inorganic materials 0.000 claims description 4
- 239000001099 ammonium carbonate Substances 0.000 claims description 4
- 235000012501 ammonium carbonate Nutrition 0.000 claims description 4
- 235000019270 ammonium chloride Nutrition 0.000 claims description 4
- 229910000148 ammonium phosphate Inorganic materials 0.000 claims description 4
- 235000019289 ammonium phosphates Nutrition 0.000 claims description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 4
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 4
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 4
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 4
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 claims description 4
- 235000013379 molasses Nutrition 0.000 claims description 4
- 239000011022 opal Substances 0.000 claims description 4
- 239000004323 potassium nitrate Substances 0.000 claims description 4
- 235000010333 potassium nitrate Nutrition 0.000 claims description 4
- MCXBMLBTPQEQJP-UHFFFAOYSA-N potassium;sodium;dinitrate Chemical compound [Na+].[K+].[O-][N+]([O-])=O.[O-][N+]([O-])=O MCXBMLBTPQEQJP-UHFFFAOYSA-N 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 108010055400 Aspartate kinase Proteins 0.000 claims description 3
- 108020004705 Codon Proteins 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 3
- 239000001888 Peptone Substances 0.000 claims description 3
- 108010080698 Peptones Proteins 0.000 claims description 3
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 3
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 3
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 3
- 239000004202 carbamide Substances 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 235000005822 corn Nutrition 0.000 claims description 3
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 claims description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 3
- 235000013312 flour Nutrition 0.000 claims description 3
- 150000002484 inorganic compounds Chemical class 0.000 claims description 3
- 229910010272 inorganic material Inorganic materials 0.000 claims description 3
- 235000013372 meat Nutrition 0.000 claims description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 3
- 125000001477 organic nitrogen group Chemical group 0.000 claims description 3
- 235000019319 peptone Nutrition 0.000 claims description 3
- 229940066779 peptones Drugs 0.000 claims description 3
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 3
- 235000002949 phytic acid Nutrition 0.000 claims description 3
- 239000000467 phytic acid Substances 0.000 claims description 3
- 229940068041 phytic acid Drugs 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 101150014006 thrA gene Proteins 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- 108010064711 Homoserine dehydrogenase Proteins 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 239000007789 gas Substances 0.000 claims description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical class O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims 2
- 229910017604 nitric acid Inorganic materials 0.000 claims 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims 1
- 239000002609 medium Substances 0.000 description 24
- 238000000855 fermentation Methods 0.000 description 16
- 230000004151 fermentation Effects 0.000 description 16
- 150000001413 amino acids Chemical class 0.000 description 15
- 229940024606 amino acid Drugs 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 12
- 230000012010 growth Effects 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 8
- 244000005700 microbiome Species 0.000 description 7
- 238000004064 recycling Methods 0.000 description 6
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 5
- 238000010924 continuous production Methods 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 241000588722 Escherichia Species 0.000 description 4
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 3
- LGVJIYCMHMKTPB-UHFFFAOYSA-N 3-hydroxynorvaline Chemical compound CCC(O)C(N)C(O)=O LGVJIYCMHMKTPB-UHFFFAOYSA-N 0.000 description 3
- 241000186226 Corynebacterium glutamicum Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 241000607720 Serratia Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000003698 anagen phase Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- MUVQIIBPDFTEKM-IUYQGCFVSA-N (2r,3s)-2-aminobutane-1,3-diol Chemical compound C[C@H](O)[C@H](N)CO MUVQIIBPDFTEKM-IUYQGCFVSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 235000019766 L-Lysine Nutrition 0.000 description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 229930195722 L-methionine Natural products 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- BVIAOQMSVZHOJM-UHFFFAOYSA-N N(6),N(6)-dimethyladenine Chemical compound CN(C)C1=NC=NC2=C1N=CN2 BVIAOQMSVZHOJM-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- JBDSSBMEKXHSJF-UHFFFAOYSA-N cyclopentanecarboxylic acid Chemical compound OC(=O)C1CCCC1 JBDSSBMEKXHSJF-UHFFFAOYSA-N 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000005189 flocculation Methods 0.000 description 2
- 230000016615 flocculation Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 229940049906 glutamate Drugs 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000003630 growth substance Substances 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 229910000358 iron sulfate Inorganic materials 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- 238000001471 micro-filtration Methods 0.000 description 2
- 238000001728 nano-filtration Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- 229920001522 polyglycol ester Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- OJCKRNPLOZHAOU-RSXXJMTFSA-N (1r,2r)-2-[(2s,4e,6e,8r,9s,11r,13s,15s,16s)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]cyclopentane-1-carboxylic acid Chemical compound O1C(=O)C[C@H](O)[C@@H](C)C[C@@H](C)C[C@@H](C)C[C@H](C)[C@@H](O)\C(C#N)=C\C=C\C[C@H]1[C@H]1[C@H](C(O)=O)CCC1 OJCKRNPLOZHAOU-RSXXJMTFSA-N 0.000 description 1
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 1
- PGNYNCTUBKSHHL-UHFFFAOYSA-N 2,3-diaminobutanedioic acid Chemical compound OC(=O)C(N)C(N)C(O)=O PGNYNCTUBKSHHL-UHFFFAOYSA-N 0.000 description 1
- QWCKQJZIFLGMSD-UHFFFAOYSA-N 2-Aminobutanoic acid Natural products CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
- CDUUKBXTEOFITR-BYPYZUCNSA-N 2-methyl-L-serine Chemical compound OC[C@@]([NH3+])(C)C([O-])=O CDUUKBXTEOFITR-BYPYZUCNSA-N 0.000 description 1
- CXABZTLXNODUTD-UHFFFAOYSA-N 3-fluoropyruvic acid Chemical compound OC(=O)C(=O)CF CXABZTLXNODUTD-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108020004652 Aspartate-Semialdehyde Dehydrogenase Proteins 0.000 description 1
- OJCKRNPLOZHAOU-BNXNOGCYSA-N Borrelidin Natural products CC1CC(C)CC(C)C(O)C(=C/C=C/CC(OC(=O)CC(O)C(C)C1)C2CCCC2C(=O)O)C#N OJCKRNPLOZHAOU-BNXNOGCYSA-N 0.000 description 1
- 241001517047 Corynebacterium acetoacidophilum Species 0.000 description 1
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- GGLZPLKKBSSKCX-YFKPBYRVSA-N L-ethionine Chemical compound CCSCC[C@H](N)C(O)=O GGLZPLKKBSSKCX-YFKPBYRVSA-N 0.000 description 1
- 229930195714 L-glutamate Natural products 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- 108010043075 L-threonine 3-dehydrogenase Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 108091000041 Phosphoenolpyruvate Carboxylase Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 241000588768 Providencia Species 0.000 description 1
- 108010053763 Pyruvate Carboxylase Proteins 0.000 description 1
- 102100039895 Pyruvate carboxylase, mitochondrial Human genes 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 102000006843 Threonine synthase Human genes 0.000 description 1
- 108010022394 Threonine synthase Proteins 0.000 description 1
- 102100033451 Thyroid hormone receptor beta Human genes 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 241000319304 [Brevibacterium] flavum Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- CDUUKBXTEOFITR-UHFFFAOYSA-N alpha-methylserine Natural products OCC([NH3+])(C)C([O-])=O CDUUKBXTEOFITR-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 229940045686 antimetabolites antineoplastic purine analogs Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000011552 falling film Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 108010071598 homoserine kinase Proteins 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001032 ion-exclusion chromatography Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- GHSJKUNUIHUPDF-UHFFFAOYSA-N s-(2-aminoethyl)-l-cysteine Chemical compound NCCSCC(N)C(O)=O GHSJKUNUIHUPDF-UHFFFAOYSA-N 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000822 sequential centrifugation Methods 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 150000003588 threonines Chemical class 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 150000003680 valines Chemical class 0.000 description 1
- 108010062110 water dikinase pyruvate Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
Definitions
- the invention relates to an improved process for the fermentative preparation of L-threonine using bacteria of the Enterobacteriaceae family.
- L-Threonine is used in animal nutrition, in human medicine and in the pharmaceuticals industry.
- L-threonine can be prepared by fermentation of strains of the Enterobacteriaceae family, in particular Escherichia coli. Because of the great importance of this amino acid, work is constantly being undertaken to improve the preparation processes . Improvements to the process can relate to fermentation measures, such as e.g. stirring and supply of oxygen, or the composition of the nutrient media, such as e.g. the sugar concentration during the fermentation, or the working up to the product form, by e.g. ion exchange chromatography, or the intrinsic output properties, i.e. those of genetic origin, of the microorganism itself.
- fermentation measures such as e.g. stirring and supply of oxygen, or the composition of the nutrient media, such as e.g. the sugar concentration during the fermentation, or the working up to the product form, by e.g. ion exchange chromatography, or the intrinsic output properties, i.e. those of genetic origin, of the microorganism itself.
- One variant of the fed batch process is the repeated fed batch process.
- some of the culture broth is removed from the fermenter at a certain point in time, e.g. when the fermenter is full, so that the feed of nutrients can be prolonged.
- US6562601 describes such a process for the production of L-threonine.
- a nutrient medium is fed to the culture continuously, while culture broth is removed continuously or semi-continuously, so that the volume of the culture broth in the fermenter remains approximately constant.
- a continuous fermentation can be operated without limitation. Prolonging the fermentation has a significantly positive effect on the overall productivity of a fermenter (average amount of product produced per hour) , since the influence of the time between two fermentations on the overall productivity of a fermenter is reduced.
- Industrial utilization of continuous processes for the preparation of amino acids is described in only isolated cases. The main reason for this lies in the degeneration of the culture often observed. Amino acids are often produced with genetically optimized microorganisms which have been selected on the basis of high substrate/product yields.
- US5763230 describes a continuous process for the preparation of amino acids, and in particular for L-lysine. In this process the growth of the cells is limited by the supplying of phosphate with simultaneous limitation of sugar; or in EP 0796616 with limitation of phosphate and / or sugar. A process was stabilized for up to 850 hours by the double limitation of growth. In the process described, a Corynebacterium glutamicum which overproduces L-lysine and is not characterized in more detail was used. It is said that the process can also be used with similar microorganisms for production of other amino acids, e.g. glutamate or threonine.
- other amino acids e.g. glutamate or threonine.
- US Patent 6025169 and FR 2669935 disclose that amino acids can be prepared by aerobic fed batch/continuous or continuous culturing with cell recycling of microorganisms. A process such that the concentration of the source of C in the medium can be kept below 5 g/1 or below 3 g/1 is described.
- L-threonine it is described therein how such a process leads to an increased formation of threonine with a lower formation of acetate in the fed batch process with Brevibacterium flavum FERM BP-1173.
- JP62-289192 describes the improvement of a continuous process for the fermentative preparation of amino acids with Corynebacterium glutamicum . Improvements were achieved by varying the carbon concentration in the nutrient solution fed in, the stirrer speed, the redox potential, the oxygen concentration and the intensity of the aeration.
- JP62-289192 describes a continuous process for the fermentative preparation of amino acids with bacteria which produce amino acids. The authors found that the process can be improved if the concentration of the source of carbon of the nutrient solution fed in continuously is above 10% and the redox potential in the culture is more than -200 mV. It is also disclosed here that the use of several fermenters can improve the utilization of the source of carbon if relatively large amounts of the starting substances remain in the culture broth removed. As examples, lysine is produced with Corynebacterium glutamicum and arginine with Corynebacterium acetoacidophilum. Miwa Harufumi describes in JP62048394 a specific continuous process for the fermentative preparation of L-glutamate.
- Substrate is fed to the reactor and culture broth is removed.
- the producing molds are separated off from the removal stream.
- the product is obtained from the supernatant and the cells are recycled into the process .
- the object of the invention is to provide new measures for improved fermentative preparation of L-threonine.
- the invention provides a fermentation process, which is characterized in that
- a bacterium of the Enterobacteriaceae family which produces L-threonine is inoculated and cultured in at least a first nutrient medium
- At least a further nutrient medium or several further nutrient media is/are then fed continuously to the culture in one (Fl) or several feed streams (Fl+) , the further nutrient medium or the further nutrient media comprising at least one source of carbon, at least one source of nitrogen and at least one source of phosphorus, under conditions which allow the formation of L-threonine, and at the same time culture broth is removed from the culture with at least one (F2) or several removal streams (F2+) which substantially corresponds/correspond to the feed stream (Fl) or the total of the feed streams (Fl+) , wherein
- the cells are completely or partly separated off from the removal stream or the removal streams (F4 or F9) with a return flow ratio, R, of 0 ⁇ R ⁇ 1 by appropriate processes and are recycled into the culturing step (b) (F5 or F10) , ⁇ . ) the threonine formed is removed, either 1) directly from the removal stream or streams (F7) or 2) after complete or partial separating off of the cells from the removal stream or the removal streams (F3), completely or partly from this or these removal streams ,
- the concentration of the source (s) of carbon during the culturing is adjusted to not more than 30 g/1.
- the product threonine is removed a) directly from the removal stream or streams (F7) or b) after complete or partial separating off of the cells from the removal stream or the removal streams (in the following, derivatives of the removal stream (F3)) completely (100%) or partly from this removal stream or from the derivatives of the removal stream.
- the culture broth remaining after removal of the threonine (with or with depleted biomass) is then fed back to the culture vessel (P8 or Fll) . If a complete or partial separating off of the biomass has taken place before the removal of the threonine, this can be combined again with the threonine- depleted stream.
- the combining can furthermore take place with previously complete or partial separating off of the biomass in the culture vessel by recycling at least two streams (one with enriched biomass (F10) and one with a reduced threonine content (Fll)) into the culture vessel.
- FIGs 1 and 2 are diagrams which represent the plant components and feed and the removal and return flow streams of processes according to the invention.
- the symbols denote the following:
- Fl a nutrient medium feed stream according to the invention
- F1+ several nutrient media feed streams according to the invention
- F2 a removal stream according to the invention
- F2+ several removal streams according to the invention
- F3 cell-depleted removal stream or F4 - F5
- F4 one or more removal streams for separating off cells
- F5 the completely recycled removal stream
- F6 stream with removed threonine or F7 - F8
- F7 one or more removal streams according to the invention for separating off threonine
- F8 the threonine-depleted recycled stream
- X separating off, according to the invention, of cells
- T separating off, according to the invention, of threonine.
- F9 one or more removal streams according to the invention for separating off cells and/or threonine;
- F10 cell- enriched stream or F9-F3; and
- Fll stream with depleted threonine .
- the culture broth remaining after removal of the threonine ( with or with depleted biomass) is then fed back to the culture vessel (F8 or Fll) .
- this (FlO) can be combined again with the threonine-depleted stream (Fll) .
- the combining can furthermore take place with previously complete or partial separating off of the biomass in the culture vessel by recycling at least two streams (one with concentrated biomass F5 or FlO and one with a reduced threonine content F8 or Fll) into the culture vessel.
- cells can be completely or partly separated off from the removal stream (F4 or F9) with a return flow ratio, R, of 0 ⁇ R ⁇ 1 by appropriate processes and can be recycled as F5 or FlO into the culturing step (b) .
- This return flow ratio is equivalent to a recycling of 0% up to and including 100% of the removed cells, preferably of 10% up to and including 100%, of 20% up to and including 100%, of 30% up to and including 100%, of 40% up to and including 100%, of 50% up to and including 100%, of 60% up to and including 100%, of 70% up to and including 100%, of 80% up to and including 100%, or of 90% up to and including 100%.
- continuous means that the feed stream or the feed streams are substantially uninterrupted. That is to sa-Y. nutrient medium or nutrient media is/are added to the culture with at most short, individual pauses. The individual interruptions or pauses are up to a maximum of 0.5, a maximum of 1, a maximum of 2 or a maximum of
- the sum of the individual interruptions or pauses in the culturing according to step b) is a maximum of 10%, a maximum of 8%, a maximum of 6%, a maximum of 4%, a maximum of 2% or a maximum of 1% of the total time of the culturing according to step b) .
- threonine is only partly removed from the removal stream or streams (F7) or the derivatives of the removal stream F3, this is separated off from 0 to less than or equal to ( ⁇ ) 10%, from 0 to ⁇ 20%, from 0 to ⁇ 30%, from 0 to ⁇ 40%, from 0 to ⁇ 50%, from 0 to ⁇ 60%, from 0 to ⁇ 70%, from 0 to ⁇ 80%, from 0 to ⁇ 90%, or from 0 to ⁇ 100%.
- the separating off of the threonine can take place here in the presence, partial presence or absence of the biomass, by using chemical or physical processes or employing combinations of the two.
- Chemical processes include extractions with chemical substances in which threonine dissolves. These include toluene, acids, e.g. hydrochloric acid, sulfuric or phosphoric acid, long-chain alcohols, e.g. butanol, pentanol or hexanol, and also carboxylic acid esters, such as e.g. ethyl acetate.
- the physical methods of separating off threonine include crystallization, for example by vacuum or cooling, filtration (for example micro-, ultra- or nanofiltration) and purification with chromatographic processes, such as, for example, ion exchange chromatography or, for example, ion exclusion chromatography. Physical extraction processes are preferred according to the invention.
- the volumetric productivity, also called the space/time yield, of a process depends not only on the output capacity of the microorganism chosen, characterized by its specific productivity, but also on the biomass concentration available in the culture system.
- the specific productivity describes the ratio of the product formed and the cell mass and is therefore a measure of the activity of the cells for product formation.
- the biomass concentration in a free culture system remains less than 50 g/1, less than 40 g/1, less than 30 g/1, or even less than 20 g/1.
- free culture system means a process without cell retention, that is to say with a free overflow.
- the cells By immobilization or cell retention systems, the cells can be utilized for product formation for longer than they are available in a free culture system.
- the specific growth rate By cell recycling the specific growth rate can be uncoupled from the dilution rate, and in particular such that the process can be operated with considerably higher dilution rates compared with a free culture system.
- the specific growth rate or specific growth speed is the ratio of the growth speed and the biomass concentration.
- the dilution rate is described by the ratio of the amount flowing through and the volume of liquid in the reactor (Horst Chmiel, Bioreatechnik: Einf ⁇ hrung in die Biovonstechnik, Gustav Fischer Verlag, Stuttgart 1991) .
- Centrifuges, separators and settlers (after flocculation) as well as cross-stream, micro- and ultra-filters are suitable for continuous separating off of cells ( Biotechnologie, by H. Weide, J. Paca and . A. Knorre,
- the return flow ratio R is defined as the ratio of the flow of the biomass-depleted permeate or sedimenter overflow or cell-depleted stream F3 to the total feed streams of the fermentation (Fl and F1+) .
- the return flow ratio should be in the range of 0 ⁇ R ⁇ 1, preferably between 0.1 ⁇ R ⁇ 1, 0.2 ⁇ R ⁇ 1, 0.3 ⁇ R ⁇ 1, 0.4 ⁇ R ⁇ 1, 0.5 ⁇ R ⁇ 1, 0.6 ⁇ R ⁇ 1, 0.7 ⁇ R ⁇ 1, 0.8 ⁇ R ⁇ 1, 0.9 ⁇ R ⁇ 1.
- the biomass concentrations are increased compared with a free culture system. That is to say, if the same microorganism is employed, according to the invention the biomass concentrations are increased by at least 5%, preferably 10%, 15%, 20%, 25%, 30%, 50%, 80%, 100%, 150%, or even by 200% or more.
- the separating off of cells can take place here, for example, by micro- or ultrafiltration in one step, or sequentially by various centrifugation or separation steps. If the separating off of the biomass takes place in one step to 100%, some of the biomass retained or the complete biomass can be recycled back into the culture vessel/the fermenter, and in particular corresponding to a return flow ratio R of 0 ⁇ R ⁇ 1.
- the return flow ratio R can be determined by a particular fraction of the centrifugate or several of or all the fractions of the centrifugates being recycled. Particular fractions can furthermore be mixed with one another in order to establish a desired return flow ratio.
- the return flow ratio is adjusted by determining the biomass concentration in the culture vessel/fermenter and/or determining the biomass concentration in the return flow.
- the biomass concentration is determined by the techniques conventionally used, such as, for example, counting the cell titer in a calibrated counting chamber, cytometrically with or without staining of the cells, determination of the optical density of the culture or by determination of the dry biomass.
- counting of the cell titer can also be automated, for example by determining the biomass concentration in a filtrate or centrifugate stage by optical methods, such as photometry or cyto etry, or by using physical methods, such as, for example, determination of the conductivity or the absorption of radiation of the near infra-red or middle infra-red range.
- the plant output of a fermentation unit which produces L-threonine can be increased by culturing by the batch process or fed batch process in the first culturing step a) described above, at least one additional nutrient medium being employed if the fed batch process is used.
- at least one further nutrient medium or several further nutrient media are fed continuously to the culture in one (Fl) or several feed streams (F1+) and at the same time culture broth is removed from the culture with at least one (F2) or several removal streams (F2+) , which substantially corresponds/correspond to the feed stream or the total of the feed streams.
- plant output is understood as meaning that in a plant, such as e.g. a fermenter, the weight or amount of a product, e.g. L-threonine, is prepared with a certain yield and with a certain space/time yield. These parameters largely determine the costs or the profitability of a process .
- the bacterium is inoculated in at least a first nutrient medium and cultured by the batch process or fed batch process. If the fed batch process is used, an additional nutrient medium is fed in after more than 0 to not more than 10 hours, preferably after 1 to 10 hours, preferentially after 2 to 10 hours and particularly preferably after 3 to 7 hours.
- the first nutrient medium comprises as the source of carbon one or more of the compounds chosen from the group consisting of sucrose, molasses from sugar beet or cane sugar, fructose, glucose, starch hydrolysate, lactose, galactose, cellulose hydrolysate, arabinose, maltose, xylose, acetic acid, ethanol and methanol, in concentrations of 1 to 50 g/kg, preferably 10 to 45 g/kg, particularly preferably 20 to 40 g/kg.
- Starch hydrolysate is understood according to the invention as the hydrolysis product of starch from maize, cereals, potatoes or tapioca.
- Organic nitrogen-containing compounds such as peptones, yeast extract, meat extract, malt extract, corn steep liquor, soya bean flour and urea
- inorganic compounds such as ammonia, ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate and ammonium nitrate, potassium nitrate and potassium sodium nitrate, can be used as the source of nitrogen in the first nutrient medium.
- the sources of nitrogen can be used individually or as a mixture in concentrations of 1 to 40 g/kg, preferably 10 to 30 g/kg, particularly preferably 10 to 25 g/kg.
- Phosphoric acid alkali metal or alkaline earth metal salts of phosphoric acid, in particular potassium dihydrogen phosphate or dipotassium hydrogen phosphate or the corresponding sodium-containing salts, polymers of phosphoric acid or the hexaphosphoric acid ester of inositol, also called phytic acid, can be used as the source of phosphorus in the first nutrient medium in concentrations of 0.1 to 5 g/kg, preferably 0.3 to 3 g/kg, particularly preferably 0.5 to 1.5 g/kg.
- the culture medium must furthermore comprise salts of metals, such as e.g. magnesium sulfate or iron sulfate, which are necessary for growth.
- the additional nutrient medium which is used in a fed batch process in general comprises merely as the source of carbon one or more of the compounds chosen from the group consisting of sucrose, molasses from sugar beet or cane sugar, fructose, glucose, starch hydrolysate, lactose, galactose, cellulose hydrolysate, arabinose, maltose, xylose, acetic acid, ethanol and methanol, in concentrations of 300 to 700 g/kg, preferably 400 to 650 g/kg, and optionally an inorganic source of nitrogen, such as e.g.
- these and other components can also be fed in separately.
- the constituents of the further nutrient medium can be fed to the culture in the form of a single further nutrient medium and in a plurality of further nutrient media.
- the further nutrient medium or the further nutrient media are fed to the culture in at least one (1) feed stream or in a plurality of feed streams of at least 2 to 10, preferably 2 to 7 or 2 to 5 feed streams .
- the further nutrient medium or the further nutrient media comprises/comprise as the source of carbon one or more of the compounds chosen from the group consisting of sucrose, molasses from sugar beet or cane sugar, fructose, glucose, starch hydrolysate, maltose, xylose, acetic acid, ethanol and methanol, in concentrations of 20 to 700 g/kg, preferably 50 to 650 g/kg.
- the further nutrient medium or the further nutrient media furthermore comprises or comprise a source of nitrogen consisting of organic nitrogen-containing compounds, such as peptones, yeast extract, meat extract, malt extract, corn steep liquor, soya bean flour and urea, or inorganic compounds, such as ammonia, ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate, ammonium nitrate and/or potassium nitrate or potassium sodium nitrate.
- the sources of nitrogen can be used individually or as a mixture in concentrations of 5 to 50 g/kg, preferably 10 to 40 g/kg.
- the further nutrient medium or the further nutrient media furthermore comprises or comprise a source of phosphorus consisting of phosphoric acid, alkali metal or alkaline earth metal salts of phosphoric acid, in particular potassium dihydrogen phosphate or dipotassium hydrogen phosphate or the corresponding sodium-containing salts, polymers of phosphoric acid or the hexaphosphoric acid ester of inositol, also called phytic acid.
- the sources of phosphorus can be used individually or as a mixture in concentrations of 0.3 to 3 g/kg, preferably 0.5 to 2 g/kg.
- the culture medium must furthermore comprise salts of metals, such as e.g.
- magnesium sulfate or iron sulfate which are necessary for growth, in concentrations of 0.003 to 3 g/kg, preferably in concentrations of 0.008 to 2 g/kg.
- essential growth substances such as amino acids (e.g. homoserine) and vitamins (e.g. thiamine) , are employed in addition to the above-mentioned substances.
- Antifoams such as e.g. fatty acid polyglycol esters, can be employed to control the development of foam.
- a single further nutrient medium is used, this is typically fed to the culture in one feed stream. If a plurality of further nutrient media are used, these are fed in a corresponding plurality of feed streams. If a plurality of further nutrient media are used, it should be noted that these in each case can comprise only one of the sources of carbon, nitrogen or phosphorus described, or also a mixture of the sources of carbon, nitrogen or phosphorus described.
- the nutrient medium fed in or the nutrient media fed in is/are adjusted such that there is a phosphorus to carbon ratio (P/C ratio) of not more than 4; of not more than 3; of not more than 2; of not more than 1.5; of not more than 1; of not more than 0.7; of not more than 0.5; of not more than 0.48; of not more than 0.46; of not more than 0.44; of not more than 0.42; of not more than 0.40; of not more than 0.38; of not more than 0.36; of not more than 0.34; of not more than 0.32; or of not more than 0.30 mmol of phosphorus / mol of carbon.
- P/C ratio phosphorus to carbon ratio
- the feed stream (Fl) or the total of the feed streams (F1+) in the process according to the invention are fed in at a rate corresponding to an average residence time of less than 30 hours, preferably less than 25, very particularly preferably less than 20 hours.
- the average residence time here is the theoretical time the particles remain in a continuously operated culture.
- the average residence time is described by the ratio of the volume of liquid in the reactor and the amount flowing through (Biotechnologie; H. Weide, . Paca and W. A. Knorre; Gustav Fischer Verlag Jena; 1991) .
- Intensive growth at the start of culturing is usually a logarithmic growth phase.
- the logarithmic growth phase is in general followed by a phase of less intensive cell growth than in the logarithmic phase.
- At least one further nutrient medium or several further nutrient media are fed continuously to the culture in one or several feed streams and at the same time culture broth is removed from the culture with at least one or several removal streams, which substantially corresponds/correspond to the feed stream or the total of the feed streams.
- substantially here means that the speed of the removal stream or the removal streams corresponds to 80% - 120%, 90% - 110% of the feed stream or of the total of the feed streams.
- the removal can be realized industrially by pumping off and/or by draining off the culture broth.
- the concentration of the source of carbon during the culturing according to step b) is in general adjusted to not more than 30 g/1, to not more than 20 g/1, to not more than 10 g/1, preferably to not more than 5 g/1, particularly preferably not more than 2 g/1. This concentration is maintained for at least 75%, preferably for at least 85%, particularly preferably for at least 95% of the culturing time according to step b) and/or c) .
- the concentration of the source of carbon is determined here with the aid of methods which are prior art.
- ⁇ -D-Glucose is determined e.g. in a YSI 02700 Select glucose analyzer from Yellow Springs Instruments (Yellow Springs, Ohio, USA) .
- the culture broth removed can be provided with oxygen or an oxygen-containing gas, optionally with stirring, until the concentration of the source of carbon falls below 2 g/1; below 1 g/1; or below 0.5 g/1.
- the yield is at least 31%, at least 33%, at least 35%, at least 37%, at least 38%, at least 40%, at least 42%, at least 44%, at least 46% or at least 48%.
- the yield is defined here as the ratio of the total amount of L-threonine formed in a culturing to the total amount of the source of carbon employed or consumed.
- L-threonine is formed with a space/time yield of at least 1.5 to 2.5 g/1 per h, of at least 2.5 to 3.5 g/1 per h, of at least 2.5 to more than 3.5 g/1 per h, of at least 3.5 to 5.0 g/1 per h, of at least 3.5 to more than 5.0 g/1 per h, or of at least 5.0 to 8.0 g/1 per h or more, such as, for example, at least 9 g/1 per h.
- the space/time yield is defined here as the ratio of the total amount of threonine formed in a culturing to the volume of the culture over the total period of time of culturing.
- the space/time yield is also called the volumetric productivity.
- the product is of course prepared in a certain yield and in a certain space/time yield (volumetric productivity) .
- L-threonine can be prepared in a yield of at least 31 % and a space/time yield of at least 1.5 to 2.5 g/1 per h. Further couplings of yield with space/time yield, such as, for example, a yield of at least 37% and a space/time yield of at least 2.5 g/1 per h, automatically result from the above statements.
- the culturing in steps a) and b) is carried out under conditions which allow the formation of L-threonine: During the culturing the temperature is adjusted in a range from 29 to 42 °c, preferably 33 to 40 9 C. The culturing can be carried out under normal pressure or optionally under increased pressure, preferably under an increased pressure of 0 to 1.5 bar.
- the oxygen partial pressure is regulated at 5 to 50%, preferably approx. 20% atmospheric saturation. During this procedure the culture is stirred and supplied with oxygen. Regulation of the pH to a pH of approx. 6 to 8, preferably 6.5 to 7.5, can be effected with 25% aqueous ammonia .
- the process according to the invention is operated for at least 72 hours, preferably 100 to 300 hours, particularly preferably 200 to > 300 hours.
- the volume of the culture is exchanged at least by half, at least 2 times, at least 4 times, at least 6 times, at least 8 times, at least 10 times, at least 12 times .
- the L-threonine can be isolated, collected or concentrated and optionally purified.
- Separation methods such as, for example, centrifugation, filtration, decanting, flocculation or a combination thereof are employed for the removal or separating off of the biomass .
- the broth obtained is then thickened or concentrated by known methods, such as, for example, with the aid of a rotary evaporator, thin film evaporator, falling film evaporator, by reverse osmosis, by nanofiltration or a combination thereof .
- This concentrated broth is then worked up by methods of freeze drying, spray drying, spray granulation or by other processes to give a preferably free-flowing, finely divided powder.
- This free-flowing, finely divided powder can then in turn be converted by suitable compacting or granulating processes into a coarse-grained, readily free-flowing, storable and largely dust-free product.
- the water is removed in total to the extent of more than 90% by this means, so that the water content in the product is less than 10%, less than 5%.
- L-threonine and other amino acids can be carried out by anion exchange chromatography with subsequent ninhydrin derivation, as described by Spackman et al. (Analytical Chemistry, 30: 1190-1206 (1958)) or it can be carried out by reversed phase HPLC, as described by Lindroth et al. (Analytical Chemistry 51: 1167-1174 (1979)) .
- Bacteria of the Enterobacteriaceae family which produce L-threonine chosen from the genera Escherichia, Erwinia, Providencia and Serratia are suitable for carrying out the process according to the invention.
- the genera Escherichia and Serratia are preferred.
- the species Escherichia coli and of the genus are preferred.
- Serratia in particular the species Serratia marcescens are to be mentioned.
- the bacteria contain at least one copy of a thrA gene or allele which codes for a threonine-insensitive aspartate kinase I - homoserine dehydrogenase I.
- a thrA gene or allele which codes for a threonine-insensitive aspartate kinase I - homoserine dehydrogenase I.
- Such bacteria are typically resistant to the threonine analogue ⁇ -amino- ⁇ - hydroxyvaleric acid (AHV) . If appropriate, the thrA gene or allele is overexpressed.
- Strains from the Enterobacteriaceae family which produce L-threonine preferably have, inter alia, one or more genetic or phenotypic features chosen from the group consisting of: resistance to ⁇ -amino- ⁇ -hydroxyvaleric acid, resistance to thialysine, resistance to ethionine, resistance to ⁇ -methylserine, resistance to diaminosuccinic acid, resistance to ⁇ -aminobutyric acid, resistance to borrelidin, resistance to cyclopentane-carboxylic acid, resistance to rifampicin, resistance to valine analogues, such as, for example, valine hydroxamate, resistance to purine analogues, such as, for example, 6-dimethylaminopurine, a need for L-methionine, optionally a partial and compensable need for L-isoleucine, a need for meso-diaminopimelic acid, auxotrophy in respect of threonine-containing dipeptide
- Escherichia in particular of the species Escherichia coli, are, for example
- Bacteria of the Enterobacteriaceae family which contain a stop codon chosen from the group consisting of opal, ochre and amber, preferably amber in the rpoS gene, and a t-RNA suppressor chosen from the group consisting of opal suppressor, ochre suppressor and amber suppressor, preferably amber suppressor, are moreover suitable.
- the amber mutation preferably lies at position 33 according to the amino acid sequence of the RpoS gene product.
- supE is preferably employed as the amber suppressor.
- the nucleotide sequence of the rpoS gene can be found in the prior art.
- the nucleotide sequence of the rpoS gene corresponding to Accession No. AE000358 is shown as SEQ ID NO. 1.
- the amino acid sequence of the associated RpoS gene product or protein is shown in SEQ ID NO. 2.
- the nucleotide sequence of an rpoS allele which contains a stop codon of the amber type at the position of the nucleotide sequence corresponding to position 33 of the amino acid sequence of the RpoS gene product or protein, corresponding to SEQ ID NO. 1 or SEQ ID NO. 2 respectively, is reproduced in SEQ ID NO. 3.
- the suppressor supE is also described in the prior art and is shown as SEQ ID NO. 4.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10335251 | 2003-08-01 | ||
| US49195903P | 2003-08-04 | 2003-08-04 | |
| DE102004030417A DE102004030417A1 (en) | 2003-08-01 | 2004-06-24 | Preparation of L-threonine useful in animal nutrition, human medicine and pharmaceuticals industry, comprises continuously feeding to bacterial culture further nutrient medium comprising source(s) of carbon, nitrogen, and phosphorus |
| PCT/EP2004/008383 WO2005014840A1 (en) | 2003-08-01 | 2004-07-27 | Process for the preparation of l-threonine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1649031A1 true EP1649031A1 (en) | 2006-04-26 |
Family
ID=34139202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP04763520A Withdrawn EP1649031A1 (en) | 2003-08-01 | 2004-07-27 | Process for the preparation of l-threonine |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP1649031A1 (en) |
| WO (1) | WO2005014840A1 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007051024A1 (en) | 2007-03-05 | 2008-09-11 | Evonik Degussa Gmbh | Process for the preparation of L-amino acids using strains of the family Enterobacteriaceae |
| EP1975241A1 (en) | 2007-03-29 | 2008-10-01 | Evonik Degussa GmbH | Method for manufacturing L-amino acids using improved strains of the enterobacteriaceae family |
| DE102007044134A1 (en) | 2007-09-15 | 2009-03-19 | Evonik Degussa Gmbh | Process for the preparation of L-amino acids using improved strains of the family Enterobacteriaceae |
| DE102007052270A1 (en) | 2007-11-02 | 2009-05-07 | Evonik Degussa Gmbh | Process for the preparation of L-amino acids using improved strains of the family Enterobacteriaceae |
| EP2060636A1 (en) | 2007-11-14 | 2009-05-20 | Evonik Degussa GmbH | Method for manufacturing L-amino acids using improved strains of the enterobacteriaceae family |
| EP2098597A1 (en) | 2008-03-04 | 2009-09-09 | Evonik Degussa GmbH | Method for manufacturing L-amino acids using improved strains of the enterobacteriaceae family |
| DE102008002309A1 (en) | 2008-06-09 | 2009-12-10 | Evonik Degussa Gmbh | Process for the preparation of L-amino acids using improved strains of the family Enterobacteriaceae |
| DE102008040352A1 (en) | 2008-07-11 | 2010-01-14 | Evonik Degussa Gmbh | Process for the preparation of L-tryptophan using improved strains of the family Enterobacteriaceae |
| DE102008044768A1 (en) | 2008-08-28 | 2010-03-04 | Evonik Degussa Gmbh | Process for the preparation of organochemical compounds using improved strains of the family Enterobacteriaceae |
| EP3385275B1 (en) | 2017-04-07 | 2019-10-23 | Evonik Degussa GmbH | Method for producing aromatic l-amino acids using improved strains of the enterobacteriaceae family |
| CN110914434A (en) * | 2017-07-11 | 2020-03-24 | 安迪苏法国联合股份有限公司 | Threonine producing yeast |
| EP3608409A1 (en) | 2018-08-09 | 2020-02-12 | Evonik Operations GmbH | Process for preparing l amino acids using improved strains of the enterobacteriaceae family |
| US11053526B2 (en) | 2018-08-09 | 2021-07-06 | Evonik Operations Gmbh | Process for preparing L amino acids using improved strains of the enterobacteriaceae family |
| CN109439702A (en) * | 2018-10-18 | 2019-03-08 | 许传高 | The technique for handling threonine high gravity fermentation waste water |
| CN109355325A (en) * | 2018-10-18 | 2019-02-19 | 许传高 | The symbiosis production. art of particle threonine and granule protein |
| EP3677594A1 (en) | 2019-01-07 | 2020-07-08 | Evonik Operations GmbH | Method for producing l-tryptophan using improved strains of the enterobacteriaceae family |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2583060B1 (en) * | 1985-06-06 | 1987-09-18 | Inst Francais Du Petrole | PRODUCTION OF BUTANOL AND ACETONE BY FERMENTATION WITH RECYCLING OF BIOMASS BY ULTRAFILTRATION |
| JPH0636746B2 (en) * | 1985-08-24 | 1994-05-18 | 味の素株式会社 | Method for producing L-glutamic acid |
| BR9105208A (en) * | 1990-11-30 | 1992-07-21 | Ajinomoto Kk | PROCESS FOR AEROBIC CULTIVATION OF A MICROORGANISM IN A Batch-fed CULTURE, CONTINUOUS CULTURE OR CONTINUOUS CULTURE CULTURE, APPLIANCE TO CONTROL THE CONCENTRATION OF THE SUBSTRATE CARBON SOURCE AND PROCESS TO PRODUCE LIS |
| DE10103778A1 (en) * | 2000-08-31 | 2002-03-14 | Degussa | New fermentation process for the production of L-threonine |
-
2004
- 2004-07-27 EP EP04763520A patent/EP1649031A1/en not_active Withdrawn
- 2004-07-27 WO PCT/EP2004/008383 patent/WO2005014840A1/en not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2005014840A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005014840A1 (en) | 2005-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Anastassiadis | L-Lysine fermentation | |
| EP1404858B1 (en) | Process for the preparation of l-amino acids using strains of the enterobacteriaceae family | |
| WO2005021772A1 (en) | Process for the preparation of l-lysine | |
| WO2005014840A1 (en) | Process for the preparation of l-threonine | |
| US20070004014A1 (en) | Method for producing l-threonine | |
| WO2005014841A1 (en) | Process for the preparation of l-threonine | |
| WO2002018543A2 (en) | Fermentation process for the preparation of l-threonine | |
| EP1896599B1 (en) | Method for producing l-threonine | |
| US8030019B2 (en) | Process for L-amino acid production using enterobacteriaceae with over-expression of ptsG gene | |
| JP2011147459A (en) | Novel bacterial strain, method of preparing the same and use thereof in fermentation process for l-lysine production | |
| Faurie et al. | Microbial production of L-amino acids | |
| US20050095688A1 (en) | Process for the preparation of L-amino acids using strains of the family Enterobacteriaceae | |
| US7122369B2 (en) | Bacterial strains, methods of preparing the same and use thereof in fermentation processes for L-lysine production | |
| US20030017556A1 (en) | Process for the preparation of L-amino acids using strains of the enterobacteiaceae family | |
| US6562601B2 (en) | Fermentation process for the preparation of L-threonine | |
| WO2005021774A1 (en) | Process for the preparation of l-lysine | |
| Shah et al. | Nutritional and mutational aspects of lysine production by Corynebacterium glutamicum auxotrophs | |
| JPH09271382A (en) | Method for producing L-amino acid by fermentation using ectoin | |
| US20030190712A1 (en) | Fermentation process for the preparation of L-threonine | |
| WO2005021773A1 (en) | Process for the preparation of l-lysine | |
| DE102004030417A1 (en) | Preparation of L-threonine useful in animal nutrition, human medicine and pharmaceuticals industry, comprises continuously feeding to bacterial culture further nutrient medium comprising source(s) of carbon, nitrogen, and phosphorus | |
| WO2005021771A2 (en) | Process for the production of l-lysine | |
| DE10210962A1 (en) | Preparation of amino acids, particularly threonine useful e.g. in animal nutrition, by growing Enterobacteriaceae having increased activity of e.g. lpd, aceE or aceF genes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20051206 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: HERMANN, THOMAS Inventor name: RIEPING, MECHTHILD Inventor name: KRUSE, DANIELA |
|
| 17Q | First examination report despatched |
Effective date: 20060703 |
|
| DAX | Request for extension of the european patent (deleted) | ||
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: DEGUSSA GMBH |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20061114 |